Univariate and multivariate analysis to identify factors associated with sustained virologic response 12 weeks after scheduled end of therapy (SVR12).

AOR: adjusted odds ratio; CI: confidence interval; IL28B: interleukin 28B.±available in 100 patients receiving TVR and 42 subject receiving BOC;¶as referred to dual therapy with peg-IFN plus RBV.Univariate and multivariate analysis to identify factors associated with sustained virologic response 12 weeks after scheduled end of therapy (SVR12).